Archives

The Scientist

The Scientist: Observing Cells in Their Natural State with Digital Holographic Cytometry

New blog article: Head over to The Scientist to read about observing cells in their natural state with digital holographic cytometry.
Patrik Eschricht and Peter Egelberg shaking hands

BioStock: PHI comments on the new senior positions in the company

BioStock reached out to Patrik Eschricht and Peter Egelberg to better understand the background behind the recent management shift.

India

PHI expands its global network to India

PHI has entered a business relationship with Medi Analytika India Pvt. Ltd. This new distributor will represent PHI in the large and growing Indian market and manage the full sales process and customer relations for the HoloMonitor® product portfolio.

PHI Focuses on Biomanufacturing — Appoints New CEO and Chairman

The Board of Directors of PHI has appointed the company’s CFO, Patrik Eschricht, as the new CEO. In addition, the former CEO and founder of PHI, Peter Egelberg, has been appointed executive chairman of the Board.
Publication-highlight

2022 publication highlights

In 2022, researchers around the world published 34 publications featuring HoloMonitor. We are thrilled to see how HoloMonitor helps scientists around the world explore new areas of study and address questions from cancer research to neuroscience.
Serious concentrated female microbiologist in sterile clothing and safety goggles sitting at table and dropping reagent in petri dish while doing research in laboratory

Interim Report 2 2022/23

The online sales and lead generation strategy continues to deliver. As a result, sales from August to October this year reached 2.7 KSEK — an increase of 50 % compared to any previous corresponding period.
PHI CSO Kersti Alm at Biostock

BioStock: PHI on the alliance for cell-based biomanufacturing

Kersti Alm, CSO at PHI, visited BioStock’s studio to talk about the recently created alliance for advancing cell-based biomanufacturing and PHI’s pivotal role in the collaboration.

PHI Is Opening A New Development Office In The US

As a result of the newly created alliance for advancing cell-based biomanufacturing which was recently communicated, PHI is taking the next step in its investment into regenerative medicine by opening an office in the Innovation Quarter in Winston-Salem.
PHI part of new regenerative medicine alliance

BioStock: PHI part of new regenerative medicine alliance

BioStock contacted Product Manager Lisa Lindström to learn more about PHI’s newly formed technology development alliance for regenerative medicine and what excites her about the future.
1131415161738